1. Home
  2. SBCF vs AMPH Comparison

SBCF vs AMPH Comparison

Compare SBCF & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seacoast Banking Corporation of Florida

SBCF

Seacoast Banking Corporation of Florida

N/A

Current Price

$32.16

Market Cap

3.3B

Sector

Finance

ML Signal

N/A

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

N/A

Current Price

$25.35

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SBCF
AMPH
Founded
1926
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
1.0B
IPO Year
2009
2005

Fundamental Metrics

Financial Performance
Metric
SBCF
AMPH
Price
$32.16
$25.35
Analyst Decision
Hold
Hold
Analyst Count
6
7
Target Price
★ $37.04
$22.50
AVG Volume (30 Days)
★ 669.8K
418.3K
Earning Date
10-26-2026
11-05-2026
Dividend Yield
★ 2.39%
N/A
EPS Growth
★ 10.56
N/A
EPS
★ 0.84
0.81
Revenue
N/A
★ $719,887,000.00
Revenue This Year
$29.76
$3.87
Revenue Next Year
$6.28
$4.90
P/E Ratio
$38.58
★ $33.02
Revenue Growth
★ N/A
N/A
52 Week Low
$28.58
$16.65
52 Week High
$36.27
$29.52

Technical Indicators

Market Signals
Indicator
SBCF
AMPH
Relative Strength Index (RSI) 28.70 61.99
Support Level $30.62 $18.51
Resistance Level $32.68 $29.40
Average True Range (ATR) 0.66 1.00
MACD -0.20 0.08
Stochastic Oscillator 0.00 51.04

Price Performance

Historical Comparison
SBCF
AMPH

About SBCF Seacoast Banking Corporation of Florida

Seacoast Banking Corp of Florida is a holding company. The company provides integrated financial services, including commercial and consumer banking, wealth management, and mortgage and insurance services, to customers across Florida through branch, mobile, and online banking solutions. It maintains day-to-day operations, particularly in the areas of operations, treasury management systems, information technology, and security. The company has one reportable segment that provides these integrated financial services, with segment revenues driven mainly by interest and fees on loans, interest on cash and cash equivalents, and investment securities, and fees on depository products and services.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: